Spoken Alpha
COOPER COMPANIES, INC.
Cooper Companies manufactures and markets contact lenses through CooperVision and fertility, women's health, and cryostorage products through CooperSurgical.
COOPER COMPANIES, INC is a Healthcare company operating in Medical Instruments & Supplies with a $10.38B market cap.
COO beat consensus EPS by 0.0% in Q3 FY2026, reported Sep 8, 2026.
23 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for COO.
$ curl https://api.spokenalpha.com/v1/companies/COOFAQ
Spoken Alpha indexes COO's earnings call transcripts at https://spokenalpha.com/companies/COO. Each call links to attributed speakers and parsed analyst Q&A. COOPER COMPANIES, INC.'s own investor relations page is at https://investor.coopercos.com/.
COOPER COMPANIES, INC. (COO) held its most recent earnings call on 2026-09-09, covering fiscal Q3 2026.
COOPER COMPANIES, INC. (COO) operates in the Healthcare sector (Medical Instruments & Supplies industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-09-08 | $1.15 | $1.11 | +3.6% | $1.07B | — | — | EODHD |
| Q2 FY2026 | 2026-06-03 | $1.21 | $1.09 | +11.0% | $1.08B | — | — | EODHD |
| Q1 FY2026 | 2026-03-04 | $1.10 | $1.03 | +6.8% | $1.02B | — | — | EODHD |
| Q4 FY2025 | 2025-12-03 | $1.15 | $1.11 | +3.6% | $1.07B | — | — | EODHD |
| Q3 FY2025 | 2025-08-26 | $1.10 | $1.07 | +2.8% | $1.06B | — | — | EODHD |
| Q2 FY2025 | 2025-05-28 | $0.96 | $0.93 | +3.2% | $1.00B | — | — | EODHD |
| Q1 FY2025 | 2025-03-05 | $0.92 | $0.91 | +1.1% | $964.7M | — | — | EODHD |
| Q4 FY2024 | 2024-12-04 | $1.04 | $1.00 | +4.0% | $1.02B | — | — | EODHD |
| Q3 FY2024 | 2024-08-27 | $0.96 | $0.91 | +5.5% | $1.00B | — | — | EODHD |
| Q2 FY2024 | 2024-05-29 | $0.85 | $0.83 | +2.4% | $942.6M | — | — | EODHD |
| Q1 FY2024 | 2024-02-28 | $0.85 | $0.78 | +9.0% | $931.6M | — | — | EODHD |
| Q4 FY2023 | 2023-12-06 | $0.87 | $0.87 | 0.0% | $927.1M | — | — | EODHD |
| Q3 FY2023 | 2023-08-29 | $0.84 | $0.84 | 0.0% | $930.2M | — | — | EODHD |
| Q2 FY2023 | 2023-05-31 | $0.77 | $0.76 | +1.3% | $877.4M | — | — | EODHD |
| Q1 FY2023 | 2023-03-01 | $0.73 | $0.67 | +9.0% | $858.5M | — | — | EODHD |
| Q4 FY2022 | 2022-12-07 | $0.69 | $0.78 | -11.5% | $848.1M | — | — | EODHD |
| Q3 FY2022 | 2022-08-30 | $0.80 | $0.81 | -1.2% | $843.4M | — | — | EODHD |
| Q2 FY2022 | 2022-06-01 | $0.81 | $0.86 | -5.8% | $829.8M | — | — | EODHD |
| Q1 FY2022 | 2022-03-02 | $0.81 | $0.78 | +3.9% | $787.2M | — | — | EODHD |
| Q4 FY2021 | 2021-12-01 | $0.82 | $0.84 | -2.4% | $759.1M | — | — | EODHD |
Source: EODHD. COO reported actuals as published; sparse fields render as —.